7 Evolution of cross-resistance to CD8+ T cells in the course of BRAF and MEK inhibitor treatment in BRAFV600E melanoma

Autor: Zhao, F., Pieper, N., Harbers, F.N., Zaremba, A., Sucker, A., Lennerz, V., Wölfel, T., Paschen, A., Schadendorf, D.
Zdroj: In ESMO Open 30 June-3 July 2018 3 Supplement 2:A3-A4
Databáze: ScienceDirect